SENZAGEN AB revenue for the last year amounted to 49.95 M SEK, the most of which — 49.87 M SEK — came from its highest performing source at the moment, Genomic Allergen Rapid Detection, the year earlier bringing 41.77 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought SENZAGEN AB 49.87 M SEK, and the year before that — 41.77 M SEK.